Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

October 31, 2008

Conditions
Actinic Keratosis
Interventions
DRUG

Fluorouracil 0.5%

Subjects will apply the smallest amount of study medication possible that is just sufficient to cover all of the affected areas daily to AK lesions

Trial Locations (1)

27157

Wake Forest University Health Sciences Dermatology, Winston-Salem

All Listed Sponsors
lead

Wake Forest University

OTHER

NCT00696488 - Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population | Biotech Hunter | Biotech Hunter